Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
NexGel Inc Warrant (NXGLW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/31/2025: NXGLW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -94.51% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/31/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 19876 | Beta 0.62 | 52 Weeks Range 0.25 - 0.95 | Updated Date 03/29/2025 |
52 Weeks Range 0.25 - 0.95 | Updated Date 03/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -37.77% | Operating Margin (TTM) -27.66% |
Management Effectiveness
Return on Assets (TTM) -21.22% | Return on Equity (TTM) -61.59% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 6322465 |
Shares Outstanding - | Shares Floating 6322465 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
NexGel Inc Warrant
Company Overview
History and Background
NexGel, Inc. is a biopharmaceutical company focused on developing and commercializing innovative hydrogel products. The warrants represent the right to purchase shares of NexGel common stock under specific terms.
Core Business Areas
- Hydrogel Technology: NexGel develops and manufactures hydrogels for various applications, including wound care, diagnostics, and cosmetic applications.
Leadership and Structure
Information on NexGel's leadership team and organizational structure is available on their investor relations website.
Top Products and Market Share
Key Offerings
- Wound Care Hydrogels: NexGel's wound care hydrogels are designed to promote healing and protect wounds. The market is competitive, with companies like 3M (MMM), Smith & Nephew (SNN), and Molnlycke Health Care AB being major players. Market share data is not readily available.
Market Dynamics
Industry Overview
The hydrogel market is growing, driven by increasing demand in wound care, drug delivery, and cosmetic applications. The market is competitive, with numerous companies developing and marketing hydrogel-based products.
Positioning
NexGel is a smaller player in the hydrogel market, focusing on innovative formulations and applications. They aim to differentiate themselves through advanced technology and specialized products.
Total Addressable Market (TAM)
The global hydrogel market is projected to reach billions of dollars. NexGel's positioning with respect to this TAM is as a niche player focusing on innovative hydrogel-based product development and commercialization.
Upturn SWOT Analysis
Strengths
- Innovative hydrogel technology
- Potential for niche market leadership
- Strategic partnerships
- Experienced management team
Weaknesses
- Limited market share
- Dependence on key partnerships
- Limited financial resources
- Regulatory hurdles
Opportunities
- Expanding into new markets
- Developing new hydrogel applications
- Acquiring complementary technologies
- Securing additional funding
Threats
- Competition from larger companies
- Technological obsolescence
- Regulatory changes
- Economic downturn
Competitors and Market Share
Key Competitors
- MMM
- SNN
Competitive Landscape
NexGel faces competition from larger, more established companies. Its advantages lie in its innovative technology and potential for niche market leadership. Disadvantages include limited resources and market share.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: NexGel's growth history depends on their past financial performance and product development milestones. Details can be sourced from official financial documentation.
Future Projections: Future growth projections depend on analyst estimates, market trends, and NexGel's strategic initiatives.
Recent Initiatives: Recent strategic initiatives are available in press releases and investor presentations from NexGel.
Summary
NexGel Inc Warrant gives investors the right to buy the underlying stock at a specified price. NexGel faces intense competition and lacks market share. While its innovative technology offers potential, it needs to secure further funding and expand partnerships to bolster future growth and strengthen market position. Investors should carefully consider the risks associated with warrants, including price volatility and limited trading liquidity.
Similar Companies
- MMM
- SNN
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Financial News Outlets
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market conditions and company performance can change rapidly, affecting the accuracy of this information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NexGel Inc Warrant
Exchange NASDAQ | Headquaters Langhorne, PA, United States | ||
IPO Launch date 2021-12-22 | CEO, President & Director Mr. Adam R. Levy | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees - | Website https://nexgel.com |
Full time employees - | Website https://nexgel.com | ||
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.